RxDoctor Payments Data

Tayanau Nunez

Family · Newnan, GANPI 1881192805

Payments from drug & device makers

$4,246in general payments, 2019–2025

Across 227 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$876
  • AbbVie$808
  • Lundbeck LLC$801
  • Takeda Pharmaceuticals U.S.A., Inc.$544
  • Tris Pharma Inc$437
  • Johnson & Johnson$238
  • plus $542 from 8 others

What the payments were for

  • Food & beverage$4,246100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,246 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl27$39,299
TrintellixVortioxetine Hydrobromide29$20,302
Aripiprazole22$1,698
Duloxetine Hcl33$1,465
Bupropion XlBupropion Hcl44$579
Sertraline Hcl61$567
Escitalopram Oxalate37$334
Buspirone Hcl34$277
Lamotrigine45$261
Trazodone Hcl55$249
Quetiapine Fumarate32$196
Hydroxyzine Hcl15$179
Oxcarbazepine13$156
Clonazepam47$148
Venlafaxine Hcl ErVenlafaxine Hcl12$143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$808$39,29927 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$544$20,30229 claims
Almatica Pharma LLCSertraline Hcl$39$56761 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Newnan

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →